78 related articles for article (PubMed ID: 1602826)
1. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
Demeter J; Paloczi K; Bibok G; Lehoczky D
Leukemia; 1992; 6 Suppl 3():41S-45S. PubMed ID: 1602826
[TBL] [Abstract][Full Text] [Related]
2. Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia.
Villamor N; Reverter JC; Montserrat E; Urbano-Ispízua A; Vives-Corrons JL; Rozman C
Leukemia; 1992 Jun; 6(6):547-52. PubMed ID: 1376376
[TBL] [Abstract][Full Text] [Related]
3. Favorable response of early stage B CLL patients to treatment with IFN-alpha 2.
Ziegler-Heitbrock HW; Schlag R; Flieger D; Thiel E
Blood; 1989 May; 73(6):1426-30. PubMed ID: 2713486
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
Boussiotis VA; Pangalis GA
Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
[TBL] [Abstract][Full Text] [Related]
5. [Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type].
Schlag R; Flieger D; Ziegler-Heitbrock HW; Hill W; Emmerich B; Thiel E
Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1088-95. PubMed ID: 2373039
[TBL] [Abstract][Full Text] [Related]
6. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
Jewell AP; Worman CP; Giles FJ; Goldstone AH
Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
[TBL] [Abstract][Full Text] [Related]
8. Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulation.
Morabito F; Callea V; Oliva B; Stelitano C; Vincelli I; Molica S; Alberti A; Brugiatelli M; Nobile F
Leukemia; 1993 Mar; 7(3):366-71. PubMed ID: 7680399
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy?
Bezares F; Kohan S; Sacerdote de Lustig E; Farías E; Murro H; Horisberger MA
J Interferon Cytokine Res; 1996 Jul; 16(7):501-5. PubMed ID: 8836914
[TBL] [Abstract][Full Text] [Related]
10. Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon. Gruppo per lo Studio e la Cura delle Gammapatie Monoclonali.
Haematologica; 1991; 76(4):298-304. PubMed ID: 1794737
[TBL] [Abstract][Full Text] [Related]
11. Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL.
Jewell AP; Yong KL; Worman CP; Tsakona CP; Giles FJ; Goldstone AH
Br J Haematol; 1994 Feb; 86(2):441-3. PubMed ID: 8199046
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre study.
Langenmayer I; Nerl C; Knauf W; Dempster S; Hallek M; Adorf D; Dietzfelbinger H; Busch R; Ziegler-Heitbrock HW; Thiel E; Emmerich B
Br J Haematol; 1996 Aug; 94(2):362-9. PubMed ID: 8759897
[TBL] [Abstract][Full Text] [Related]
13. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia.
McSweeney EN; Giles FJ; Worman CP; Jewel AP; Tsakona CP; Hoffbrand AV; Mehta AB; Newland AC; Cawley JC; Galvani D
Br J Haematol; 1993 Sep; 85(1):77-83. PubMed ID: 8251412
[TBL] [Abstract][Full Text] [Related]
15. [Effect of treatment with recombinant interferon alfa on natural killer activity in patients with chronic type B lymphatic leukemia].
Villamor N; Montserrat E; Urbano-Ispízua A; Ribera JM; Rovira M; Vives Corrons JL; Rozman C
Sangre (Barc); 1989 Dec; 34(6):485-8. PubMed ID: 2629126
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial with alpha 2b-interferon in 26 stage A untreated B-chronic lymphocytic leukemia patients.
Boussiotis VA; Pangalis GA
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):471-3. PubMed ID: 3065744
[TBL] [Abstract][Full Text] [Related]
17. [Nephrotic syndrome associated with B-cell chronic lymphocytic leukemia successfully treated with interferon-alpha].
Nakayama S; Yabe H; Nagai K
Rinsho Ketsueki; 1990 Dec; 31(12):1924-8. PubMed ID: 2079729
[TBL] [Abstract][Full Text] [Related]
18. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
[TBL] [Abstract][Full Text] [Related]
19. Transient regression in lymphocyte count in B-cell chronic lymphocytic leukemia after viral infection.
Shirono K; Ikebe M; Inada T; Tsuda H
Acta Haematol; 1995; 93(1):46-9. PubMed ID: 7725850
[TBL] [Abstract][Full Text] [Related]
20. Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL).
Mandelli F; Gastaldi R; Monarca B; Coluzzi S; De Rossi G
Eur J Haematol; 1991 Jan; 46(1):58-9. PubMed ID: 1988312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
